Cargando…
Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597523/ https://www.ncbi.nlm.nih.gov/pubmed/36306801 http://dx.doi.org/10.1016/S2468-1253(22)00340-5 |
| _version_ | 1784816111444819968 |
|---|---|
| author | Quan, Joshua Ma, Christopher Panaccione, Remo Hracs, Lindsay Sharifi, Nastaran Herauf, Michelle Markovinović, Ante Coward, Stephanie Windsor, Joseph W Caplan, Léa Ingram, Richard J M Charlton, Carmen Kanji, Jamil N Tipples, Graham Holodinsky, Jessalyn K Bernstein, Charles N Mahoney, Douglas J Bernatsky, Sasha Benchimol, Eric I Kaplan, Gilaad G |
| author_facet | Quan, Joshua Ma, Christopher Panaccione, Remo Hracs, Lindsay Sharifi, Nastaran Herauf, Michelle Markovinović, Ante Coward, Stephanie Windsor, Joseph W Caplan, Léa Ingram, Richard J M Charlton, Carmen Kanji, Jamil N Tipples, Graham Holodinsky, Jessalyn K Bernstein, Charles N Mahoney, Douglas J Bernatsky, Sasha Benchimol, Eric I Kaplan, Gilaad G |
| author_sort | Quan, Joshua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9597523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95975232022-10-26 Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease Quan, Joshua Ma, Christopher Panaccione, Remo Hracs, Lindsay Sharifi, Nastaran Herauf, Michelle Markovinović, Ante Coward, Stephanie Windsor, Joseph W Caplan, Léa Ingram, Richard J M Charlton, Carmen Kanji, Jamil N Tipples, Graham Holodinsky, Jessalyn K Bernstein, Charles N Mahoney, Douglas J Bernatsky, Sasha Benchimol, Eric I Kaplan, Gilaad G Lancet Gastroenterol Hepatol Correspondence Elsevier Ltd. 2022-12 2022-10-26 /pmc/articles/PMC9597523/ /pubmed/36306801 http://dx.doi.org/10.1016/S2468-1253(22)00340-5 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Quan, Joshua Ma, Christopher Panaccione, Remo Hracs, Lindsay Sharifi, Nastaran Herauf, Michelle Markovinović, Ante Coward, Stephanie Windsor, Joseph W Caplan, Léa Ingram, Richard J M Charlton, Carmen Kanji, Jamil N Tipples, Graham Holodinsky, Jessalyn K Bernstein, Charles N Mahoney, Douglas J Bernatsky, Sasha Benchimol, Eric I Kaplan, Gilaad G Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title | Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title_full | Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title_fullStr | Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title_full_unstemmed | Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title_short | Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease |
| title_sort | serological responses to the first four doses of sars-cov-2 vaccine in patients with inflammatory bowel disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597523/ https://www.ncbi.nlm.nih.gov/pubmed/36306801 http://dx.doi.org/10.1016/S2468-1253(22)00340-5 |
| work_keys_str_mv | AT quanjoshua serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT machristopher serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT panaccioneremo serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT hracslindsay serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT sharifinastaran serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT heraufmichelle serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT markovinovicante serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT cowardstephanie serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT windsorjosephw serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT caplanlea serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT ingramrichardjm serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT charltoncarmen serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT kanjijamiln serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT tipplesgraham serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT holodinskyjessalynk serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT bernsteincharlesn serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT mahoneydouglasj serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT bernatskysasha serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT benchimolerici serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT kaplangilaadg serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease AT serologicalresponsestothefirstfourdosesofsarscov2vaccineinpatientswithinflammatoryboweldisease |